Aids in diagnosis of CSF leak.
Qualitative Immunofixation Electrophoresis
New York DOH Approval Status
Aural or nasal fluid in sterile container.
Transport 2 mL aural or nasal fluid in a tube without preservative. (Min: 1 mL aural or nasal fluid)
Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks
Detection of a beta-2 transferrin band by IFE is diagnostic for the presence of cerebrospinal fluid (CSF). This test is useful in the differential diagnosis for CSF otorrhea or CSF rhinorrhea. Beta-2 transferrin is not detected by this methodology in normal serum, tears, saliva, sputum, nasal, or aural fluid.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
The beta-2 transferrin protein assay by IFE methodology is not a reliable method for detecting human perilymph due to the low sensitivity of the assay.
|Component Test Code*||Component Chart Name||LOINC|
- Cerebrospinal Fluid Leakage
- Transferrin, Spinal Fluid
- B2 Transferrin
- CSF Leakage Detection
- CSF Specific Transferrin
- CSF-Specific Transferrin
- Desialated Transferrin
- Tau CSF Protein
- Transferrin B2